Italia markets close in 7 hours 2 minutes

Organogenesis Holdings Inc. (ORGO)

NasdaqCM - NasdaqCM Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
2,2850-0,6950 (-23,32%)
Alla chiusura: 04:00PM EDT
2,3300 +0,04 (+1,97%)
Dopo ore: 07:58PM EDT
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente2,9800
Aperto2,9100
Denaro2,2700 x 200
Lettera2,3000 x 300
Min-Max giorno2,1650 - 2,9300
Intervallo di 52 settimane1,8700 - 4,7050
Volume2.555.044
Media Volume837.233
Capitalizzazione301,535M
Beta (5 anni mensile)1,57
Rapporto PE (ttm)57,13
EPS (ttm)0,0400
Prossima data utili08 mag 2024 - 13 mag 2024
Rendimento e dividendo (futuro)N/D (N/D)
Data ex dividendoN/D
Stima target 1A4,83
  • GlobeNewswire

    Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2023 Financial Results on November 9, 2023

    CANTON, Mass., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced that third quarter of fiscal year 2023 financial results will be reported after the market closes on Thursday, November 9th. Management will host a conference call at 5:00 p.m. Eastern Time on Novemb

  • GlobeNewswire

    Organogenesis Applauds Withdrawal of Local Coverage Determinations by Novitas, First Coast Service Options and CGS

    Thanks Stakeholders who Advocated for PatientsCANTON, Mass., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, applauds today’s decision by the three Medicare Administrative Contractors (MACs) to withdraw the final local coverage determinations (LCDs) for Skin Substitute Graft

  • GlobeNewswire

    Organogenesis Holdings Inc. to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

    CANTON, Mass. , Sept. 06, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced that company management will participate in the Morgan Stanley 21st Annual Global Healthcare Conference, which is being held at the Sheraton New York Times Square Hotel in New York, NY from Septemb